During the past decade, Centro de Diálisis Terrassa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Diálisis Terrassa" are "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Kidney Diseases" (1 trials), "Hemodialysis" (1 trials) and "Renal Failure" (1 trials). Many other conditions were trialed in "Centro de Diálisis Terrassa" in a lesser frequency.

Most popular intervention types in "Centro de Diálisis Terrassa" are "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood samples" (1 trials) and "T50 Calcification Inhibition Test (CIT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Diálisis Terrassa" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Diálisis Terrassa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Diálisis Terrassa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Diálisis Terrassa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".